Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines
N. Principi, S. Esposito
semanticscholar +1 more source
Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland [PDF]
Kristiana Alexandrova Nikolova +3 more
openalex +1 more source
Splenectomized patients make IgG antibodies to 23-valent non-conjugated pneumococcal vaccine despite having reduced circulating CD27+ memory B cells [PDF]
Heather A. Wasserstrom +6 more
openalex +1 more source
Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system (VAERS) database. [PDF]
Zheng X +8 more
europepmc +1 more source
Inflammatory Knee Reaction Mimicking Septic Arthritis Following Closely Spaced Pneumococcal Vaccines in a Pediatric Patient Undergoing Immunodeficiency Evaluation. [PDF]
Soule SM +5 more
europepmc +1 more source
Cost-Effectiveness Analysis of Pneumococcal Vaccines in the Pediatric Population: A Systematic Review. [PDF]
Vo NX, Pham HL, Bui UM, Ho HT, Bui TT.
europepmc +1 more source
Correction: Omole et al. Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. <i>Vaccines</i> 2025, <i>13</i>, 192. [PDF]
Omole T +12 more
europepmc +1 more source
The Effectiveness of Four Quadrivalent, Inactivated Influenza Vaccines Administered Alone or in Combination with Pneumococcal and/or SARS-CoV-2 Vaccines: A Population-Wide Cohort Study [PDF]
Cecilia Acuti Martellucci +12 more
openalex +1 more source

